The dystroglycan complex: From biology to cancer

Journal of Cellular Physiology

Volumn 205, Issue 2, 2005, Pages 163-169

  Sgambato, Alessandro ^a   Brancaccio, Andrea ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DYSTROGLYCAN; GLYCOPROTEIN;

BASEMENT MEMBRANE; CANCER PATIENT; CELL GROWTH; CELL MEMBRANE; CELL POLARITY; CENTRAL NERVOUS SYSTEM; COMPLEX FORMATION; CYTOSKELETON; EPITHELIUM CELL; HUMAN; HUMAN CELL; MORPHOGENESIS; MUSCULAR DYSTROPHY; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SKELETAL MUSCLE; TUMOR GROWTH;

ANIMALS; BIOLOGY; DYSTROGLYCANS; FORECASTING; HUMANS; NEOPLASMS;

EID: 26444466088     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20411     Document Type: Review

References (75)

1. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. 2004. Genetic compensation for sarcoglycan loss by integrin α7β1 in muscle. J Cell Sci 117:3821-3830.
2. Bies RD, Maeda M, Roberds SL, Holder E, Bohlmeyer T, Young JB, Campbell KP. 1997. A 5′ dystrophin duplication mutation causes membrane deficiency of α-dystroglycan in a family with X-linked cardiomyopathy. J Mol Cell Cardiol 29:3175-3188.
3. Bozic D, Sciandra F, Lamba D, Brancaccio A. 2004. The structure of the N-terminal region of murine skeletal muscle α-dystroglycan discloses a modular architecture. J Biol Chem 279:44812-44816.
4. Bozzi M, Bianchi M, Sciandra F, Paci M, Giardina B, Brancaccio A, Cicero DO. 2003. Structural characterization by NMR of the natively unfolded extracellular domain of β-dystroglycan: Toward the identification of the binding epitope for β-dystroglycan. Biochemistry 42:13717-13724.
5. Bozzi M, Di Stasio E, Cicero DO, Giardina B, Paci M, Brancaccio A. 2004. The effect of an ionic detergent on the natively unfolded β-dystroglycan ectodomain and on its interaction with α-dystroglycan. Protein Sci 13:2437-2445.
6. Brancaccio A, Schulthess T, Gesemann M, Engel J. 1995. Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett 368:139-142.
7. Brancaccio A, Schulthess T, Gesemann M, Engel J. 1997. The N-terminal region of α-dystroglycan is an autonomous globular domain. Eur J Biochem 246:166-172.
8. Cao W, Henry MD, Borrow P, Yamada H, Elder JH, Ravkov EV, Nichol ST, Compans RW, Campbell KP, Oldstone MB. 1998. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079-2081.
9. Cavaldesi M, Macchia G, Barca S, Defilippi P, Tarone G, Petrucci TC. 1999. Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neurochem 72:1648-1655.
10. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, Kanazawa I, Kobata A, Endo T. 1997. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin. J Biol Chem 272:2156-2162.
11. Chockalingam PS, Cholera R, Oak SA, Zheng Y, Jarrett HW, Thomason DB. 2002. Dystrophin-glycoprotein complex and Ras and Rho GTPase signaling are altered in muscle atrophy. Am J Physiol Cell Physiol 283:500-511.
12. Cohn RD, Campbell KP. 2000. Molecular basis of muscular dystrophies. Muscle Nerve 23:1456-1471.
13. Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, Flanagan JD, Skwarchuk MW, Robbins ME, Mendell JR, Williamson RA, Campbell KP. 2002. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell 110:639-648.
14. Cote PD, Moukhles H, Lindenbaum M, Carbonetto S. 1999. Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23:338-342.
15. Dudley RW, Lu Y, Gilbert R, Matecki S, Nalbantoglu J, Petrof BJ, Karpati G. 2004. Sustained improvement of muscle function one year after full-length dystrophin gene transfer into mdx mice by a gutted helper-dependent adenoviral vector. Hum Gene Ther 15:145-156.
16. Durbeej M, Campbell KP. 1998. Biochemical characterization of the epithelial dystroglycan complex. J Biol Chem 274:26609-26616.
17. Durbeej M, Talts JF, Henry MD, Yurchenco PD, Campbell KP, Ekblom P. 2001. Dystroglycan binding to laminin α1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69:121-134.
18. Ervasti JM, Campbell KP. 1993. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823.
19. Esapa CT, Bentham GR, Schroder JE, Kroger S, Blake DJ. 2003. The effects of post-translational processing on dystroglycan synthesis and trafficking. FEBS Lett 555:209-216.
20. Ferletta M, Kikkawa Y, Yu H, Talts JF, Durbeej M, Sonnenberg A, Timpl R, Campbell KP, Ekblom P, Genersch E. 2003. Opposing roles of integrin alpha6Abeta1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation. Mol Biol Cell 14:2088-2103.
21. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, Terrett JA. 2003. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4α and dystroglycan. Br J Cancer 88:579-585.
22. Gesemann M, Cavalli V, Denzer AJ, Brancaccio A, Schumacher B, Ruegg MA. 1996. Alternative splicing of agrin alters its binding to heparin, dystroglycan, the putative agrin receptor. Neuron 16:755-767.
23. Gesemann M, Brancaccio A, Schumacher B, Ruegg MA. 1998. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. J Biol Chem 273:600-605.
24. Ghen Y, Spence HJ, Cameron JM, Jess T, Ilsley JL, Winder SJ. 2003. Direct interaction of β-dystroglycan with F-actin. Biochem J 375:329-337.
25. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, Sanes JR. 2000. Maturation and maintenance of the neuromuscular synapse: Genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25:279-293.
26. Gui GPH, Puddefoot JR, Vinson GP, Wells CA, Carpenter R. 1997. Altered cell-matrix contact: A prerequisite for breast cancer metastasis? Br J Cancer 75:623-633.
27. Haliloglu G, Topaloglu H. 2004. Glycosylation defects in muscular dystrophies. Curr Opin Neurol 17:521-527.
28. Henry MD, Campbell KP. 1998. A role for dystroglycan in basement membrane assembly. Cell 95:859-870.
29. Henry MD, Cohen MB, Campbell KP. 2001. Reduced expression of dystroglycan in breast and prostate cancer. Hum Pathol 32:791-795.
30. Herzog C, Has C, Franzke C-W, Echtermeyer F, Schlotzer-Schrehardt U, Kroger S, Gustafsson E, Fassler R, Bruckner-Tuderman L. 2004. Dystroglycan in skin and cutaneous cells: β-subunit is shed from the cell surface. J Invest Dermatol 122:1372-1380.
31. Holt KH, Crosbie RH, Venzke DP, Campbell KP. 2000. Biosynthesis of dystroglycan: Processing of a precursor peptide. FEBS Lett 468:79-83.
32. Huang X, Poy F, Zhang R, Joachimiak A, Sudol M, Eck MJ. 2000. Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan. Nat Struct Biol 7:634-638.
33. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
34. Ibraghimov-Beskrovnaya O, Mialtovich A, Ozcelik T, Yang B, Koepnick K, Francke U, Campbell KP. 1993. Human dystroglycan; Skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Genet 2:1651-1657.
35. Ilsley JL, Sudol M, Winder SJ. 2001. The interaction of dystrophin with P-dystroglycan is regulated by tyrosine phosphorylation. Cell Signal 13:625-632.
36. James M, Nuttall A, Ilsley JL, Ottersbach K, Tinsley JM, Sudol M, Winder SJ. 2000. Adhesion-dependent tyrosine phosphorylation of β-dystroglycan regulates its interaction with utrophin. J Cell Sci 113:1717-1726.
37. Jayasinha V, Nguyen HH, Xia B, Kammesheidt A, Hoyte K, Martin PT. 2003. Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice. Neuromuscul Disord 13:365-375.
38. Jing J, Lien CF, Sharma S, Rice J, Brennan PA, Gorecki DC. 2004. Aberrant expression, processing and degradation of dystroglycan in squamous cell carcinomas. Eur J Cancer 40:2143-2151.
39. Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, Campbell KP. 2004. Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117:953-964.
40. Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB. 2001. Molecular analysis of the interaction of LCMV with its cellular receptor α-dystroglycan. J Cell Biol 155:301-310.
41. Kunz S, Campbell KP, Oldstone MB. 2003. α-Dystroglycan can mediate arena-virus infection in the absence of β-dystroglycan. Virology 316:213-220.
42. Langenbach KJ, Rando TA. 2002, Inhibition of dystroglycan binding to laminin disrupts the PI3K/AKT pathway and survival signaling in muscle cells. Muscle Nerve 26:644-653.
43. Lapidos KA, Kakkar R, McNally EM. 2004. The dystrophin glycoprotein complex: Signaling strength and integrity for the sarcolemma. Circ Res 94:1023-1031.
44. Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F. 2003. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan. Hum Mol Genet 12:2853-2861.
45. Losasso C, Di Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, Petrucci TC, Brancaccio A. 2000. Anomalous dystroglycan in carcinoma cell lines. FEBS Letters 484:194-198.
46. Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T, Uchida N, Takeda Y, Kasai H, Okamoto H, Tsuzuki H, Kambayashi Y, Watanabe F, Kawada K, Toda K, Ohtani M, Sugita K, Yoshioka T. 1999. Correlation of antiangiogenic and antitumor efficacy of N-biphenylo sulfonyl-phenlalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res 59:1231-1235.
47. Matsumura K, Chiba A, Yamada H, Fukuta-Ohi H, Fujita S, Endo T, Kobata A, Anderson LV, Kanazawa I, Campbell KP, Shimizu T. 1997. A role of dystroglycan in schwannoma cell adhesion to laminin. J Biol Chem 272:13904-13910.
48. Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP. 2002. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 418:422-425.
49. Muntoni F, Brockington M, Torelli S, Brown SC. 2004. Defective glycosylation in congenital muscular dystrophies. Curr Opin Neurol 17:205-209.
50. Parsons MJ, Campos I, Hirst EM, Stemple DL. 2002. Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos. Development 129:3505-3512.
51. Pavoni E, Sciandra F, Barca S, Giardina B, Petrucci TC, Brancaccio A. 2005. Immunodetection of partially glycosylated isoforms of α-dystroglycan by a new monoclonal antibody against its β-dystroglycan-binding epitope. FEBS Lett 579:493-499.
52. Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA. 1998. Role of α-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 282:2076-2079.
53. Rudenko G, Hohenester E, Muller YA. 2001. LG/LNS domains: Multiple functions-one business end? Trends Biochem Sci 26:363-368.
54. Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci TC. 2000. Characterization of the β-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 274:93-98.
55. Saito F, Moore SA, Barresi R, Henry MD, Messing A, Ross-Barta SE, Cohn RD, Williamson RA, Sluka KA, Sherman DL, Brophy PJ, Schmelzer JD, Low PA, Wrabetz L, Feltri ML, Campbell KP. 2003. Unique role of dystroglycan in peripheral nerve myelination, nodal structure, sodium channel stabilization. Neuron 38:747-758.
56. Sciandra F, Schneider M, Giardina B, Baumgarther S, Petrucci TC, Brancaccio A. 2001. Identification of the β-dystroglycah binding epitope within the C-terminal region of α-dystroglycan. Eur J Biochem 268:4590-4597.
57. Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentirti GP, Cittadini A. 2003. Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162:849-860.
58. Sgambato A, Camerini A, Montanari M, Camerini A, Brancaccio A, Spada D, Cangiano R, Losasso C, Capelli G, Trentini G, Cittadini A. 2004. Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol and Ther 3:849-860.
59. Shimizu H, Hosokawa H, Ninomiya H, Mineres JH, Masaki T. 1999. Adhesion of cultured bovine aortic endothelial cells to laminin-1 mediated by dystroglycan. J Biol Chem 274:11995-12000.
60. Singh J, Itahana Y, Knight-Krajewski S, Kanagawa M, Campbell KP, Bissell MJ, Muschler J. 2004. Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res 64:6152-6159.
61. Smalheiser NR, Haslam SM, Sutton-Smith M, Morris HR, Dell A. 1998. Structural analysis of sequences O-linked to marinose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain. J Biol Chem 273:23698-23703.
62. Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP. 2001. Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40:14585-14592.
63. Spence HJ, Dhillon AS, James M, Winder SJ. 2004a. Dystroglycan, a scaffold for the ERK-MAP kinase cascade. EMBO Rep 5:1-6.
64. Spence HJ, Chen Y-J, Batchelor CL, Higginson JR, Suila HO, Carpen O, Winder SJ. 2004b. Ezrin-dependent regulation of the actin cytoskeleton by β-dystroglycan. Hum Mol Genet 13:1657-1668.
65. Straub V, Ettinger AJ, Durbeej M, Venzke DP, Cutshall S, Sanes JR, Campbell KP. 1999. ε-Sarcoglycan replaces α-sarcoglycan in smooth muscle to form a unique dystrophin-glycoprotein complex. J Biol Chem 274:27989-27996.
66. Suzuki K, Takahashi K. 2003. Reduced cell adhesion during mitosis by threonine phosphorylation of β1 integrin. J Cell Physiol 197:297-305.
67. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ. 2002. A role for dystroglycan in epithelial polarization: Loss of function in breast tumor cells. Cancer Res 62:7102-7109.
68. Werner JA, Rathcke IO, Madic R. 2002. The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19:275-282.
69. Willer T, Prados B, Falcon-Perez JM, Renner-Muller I, Przemeck GK, Lommel M, Coloma A, Valero MC, de Angelis MH, Tanner W, Wolf E, Strahl S, Cruces J. 2004. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. Proc Natl Acad Sci USA 101:14126-14131.
70. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. 1997. Dystroglycan is essential for early embryonic development: Disruption of Reichert's membrane in Dagl-null mice. Hum Mol Genet 6:831-841.
71. Winder SJ. 2001. The complexities of dystroglycan. TIBS 26:118-124.
72. Wizemann H, Garbe JH, Friedrich MV, Timpl R, Sasaki T, Hohenester E. 2003. Distinct requirements for heparin and α-dystroglycan binding revealed by structure-based mutagenesis of the laminin a2 LG4-LG5 domain pair. J Mol Biol 332:635-642.
73. Yamada H, Saito F, Fukuta-Ohi H, Zhong D, Hase A, Arai K, Okuyama A, Maekawa R, Shimizu T, Matsumura K. 2001. Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genetics 10:1563-1569.
74. Yang B, Jung D, Motto D, Meyeer J, Koretzky G, Campbell KP. 1995. SH3 domain mediated interaction of dystroglycan and Grb2. J Biol Chem 270:11711-11714.
75. Zaccaria ML, Di Tommaso F, Brancaccio A, Paggi P, Petrucci TC. 2001. Dystroglycan distribution in adult mouse brain: A light and electron microscopic study. Neuroscience 104:311-324.